Tackling Urinary Tract Infection: part of the Paradigm Shift in HCAI Management in Hywel Dda UHB Dr Mike Simmons.

Slides:



Advertisements
Similar presentations
Saranaz Jamdar Consultant Microbiologist
Advertisements

Quality improvement guide: prevention and control of healthcare-associated infections Learning and development resource for board members 2012 NICE public.
Intravenous Drug Administration
Developments from the National Quality Board: A New Objective for MRSA Derek Butler Registered Charity No
Infection Prevention and Control Jo Lickiss Nurse Consultant Infection Prevention and Control.
Asymptomatic bacteriuria in the elderly Dr Grace Sluga Consultant Microbiologist.
The Welsh context – Smoking cessation in Wales and current targets Sue Bowker Tobacco Policy Welsh Government
Information for Action Point Prevalence Survey of Healthcare associated infection and antimicrobial use 26 th June 2012 Dafydd Williams.
CAUTI Prevention.
Microbiology ICE Requesting: Index of Topics
April 11 th 2014 Putting a S.T.O.P to traditional use of Invasive Devices: Use it or lose it! Liz Smith.
Infection Prevention & Control Neil Wigglesworth Nurse Consultant, Infection Control 23 rd June 2008.
Infection control annual report April 2005 to March 2006 Dr Graham Harvey Consultant Microbiologist Director of Infection Prevention & Control.
HEALTH CARE ASSOCIATED INFECTION دکترافشین محمد علیزاده متخصص عفونی عضوهیئت علمی دانشگاه علوم پزشکی شهیدبهشتی بیمارستان آیت ا...طالقانی.
PENNINE ACUTE HOSPITALS NHS TRUST HCAI RECOVERY Vic Crumbleholme/Louise Dickinson Associate Director of Nursing/Nurse Consultant Prevention & Control of.
Quality Education for a Healthier Scotland Blood Cultures.
Problematic and injecting drug use – findings from the Harm Reduction Database (HRD) Presenter: Josie Smith, Health Protection, PHW.
Insert name of presentation on Master Slide Health Care Associated Infections: Invasive Devices November 2011 Presenter: Liz Smith.
Dr Michelle Webb Renal Consultant, Associate Medical Director Patient Safety, East Kent Hospitals University NHS Foundation Trust and Co-lead for Sepsis.
Insert name of presentation on Master Slide Transforming Maternity Services Mini-Collaborative Introductory WebEx Call Thursday 4 th May 2011 Call Facilitator.
Nursing Orientation. All staff AND visitors should follow the precautions listed on the sign All PPE (personal protective equipment) should be on prior.
Care bundle for PVC Insertion and Ongoing Aneurin Bevan Health Board Our story so far…….
Implementation of a Quality Management System across a Network of Microbiology Laboratories Presenter: Anne Thomas Health Protection Quality Improvement.
Harm from Invasive Devices Dr. Eleri Davies, Faculty Lead HCAI.
1 Healthcare Associated Infections & Antimicrobial Consumption in Long-Term Care Facilities. (HALT) Mags Moran & Mary Rooney Community Infection Control.
Could it happen here Campaign Patient died of Clostridium difficile.
Insert name of presentation on Master Slide Annual Quality Framework Quality & Safety improvement Reporting.
Hospital Engagement Network
Wales Primary Care COPD Audit
Peripheral Vascular Cannulas so far ……..
Making the most of your culture surveys
Infection Prevention and Control
Invasive Devices WebEx
Indication A Systemic Inflammatory Response Syndrome (SIRS)* OR
Tackling antimicrobial resistance and improving antibiotic prescribing
Cardiac Diagnostic Waits National Cardiac Services Review Day
Strategies to Reduce Antibiotic Resistance and to Improve Infection Control Robin Oliver, M.D., CPE.
Mortality and harm Learning Set. National context update
Welcome Dr. Eleri Davies, Faculty Lead HCAI.
Sharn Elton Ashish Shah Alison Shelley July 2016
Professor Alan Johnson Department of HCAI & AMR
Child Measurement Programme for Wales maps 2015/16
Bacteraemia in Buckinghamshire Healthcare NHS Trust
Frailty Programme Fran Rose-Smith June 2018.
My name is and I’m here from to talk to you about medication safety. (Be sure to fill our your name in the slide).
CSI 101 Skills Lab 3 Universal Precautions and
Powys teaching Health Board
HAI August 30, 2017.
HAI January 24, 2018.
Mortality and harm reduction in Cardiff and Vale UHB
MQii Root Cause Analysis Overview
HAI Sept. 25, 2017.
Hot Topics: Making sure we don’t drown in data
Welcome / Croeso Dr. Eleri Davies
> 24,000 people waiting > 270,000 days waited in each speciality
HCAI Tier 1 Targets Mari Morgan, WHAIP
Clinical Governance Practice Self Assessment Tool (CGPSAT) update
ABMU Antibiotic Audits An Update
Improving wound management through inter-professional collaboration.
Recognising sepsis and taking action
Data Collection Training, Part I Outcome Data
To Dip Or Not To Dip – Improving the management of Urinary Tract Infection in older people Improving Patient Safety & Care 6th Feb 2019 Continuous Learning,
Sharing information to understand the shared issues
The Public Health Wales website
Annual Quality Framework
Prudent healthcare in NHS Wales
Child Measurement Programme for Wales report 2017/18
Implementing Interventions – Success from 1000 Lives Campaign
Cardiff and Vale UHB Dr Graham Shortland
Presentation transcript:

Tackling Urinary Tract Infection: part of the Paradigm Shift in HCAI Management in Hywel Dda UHB Dr Mike Simmons

MRSA context 2013

C diff context in 2014

Blood cultures 2013

Top Ten Bacteraemia 2014 All Wales 81 24 14 9 7 5 4 3 Rate/100,000 bed days E coli MSSA Enterococcus Klebsiella Pneumo CNS Proteus Ps. Aeruginosa MRSA Enterobacter Aneurin Bevan 76 19 12 10 <4 6 Abertawe Bro Morgannwg 79 25 15 11 Betsi Cadwaladr 85 20 <3 Cardiff and Vale 69 29 17 <5 8 Cwm Taf 86 28 13 Hywel Dda 108 33 21

Top Five Bacteraemia 83% over 60 64% over 70

Top Five Bacteraemia

E. Coli Enhanced Surveillance April to June 2014

Hypothesis RCA of MRSA and C diff = antibiotic use Sepsis presenting in secondary care must be treated Reduce sepsis presentations → reduce exposure to antibiotics → reduce MRSA and C diff Whole health economy approach: infection prevention in the community as well as secondary care

The Paradigm Shift in Hywel Dda Continue to see all infections as intolerable i.e. Zero Tolerance to HCAI Recognise the big three: Respiratory Infection Urinary Infection Skin and Surgical Site Infection Engage, energise and empower all staff across the acute and community sector with special efforts to get upstream into the community

The Paradigm Shift in Hywel Dda Accept that Welsh Government will continue to challenge around MRSA and C diff Monitor E coli bacteraemia as a better surrogate for infections across our services

Prudence and Complexity: Actions to reduce HCAI Complexity science Squeeze multiple issues simultaneously Test every initiative or intervention with 2 rules: First: do no harm Second: seek and take the positive step or action

Evidence? Best kept HCAI public “secret” in Wales Caesarean section surgical site infection reductions

Evidence?

Transformational change Minimal Viable Transformation (MVT): change should be small and imperfect---- Deloitte ---- ‘Our transformation process is going to be small and imperfect -- we are going to do many small things that probably wont work straight away. However we will learn lessons from these ‘experiments’ and apply the learning to a better next small thing, making sure we progressively move towards the right direction -------- ‘ Ref: @whatsthepont

So What’s the Pont? Most transformation programmes are about BIG ideas where there is little room for failure Testing and development of small ideas is much lower risk and potentially leads to solutions that work better for people The Minimum Viable Product (MVP) approach offers something different that could be widely applied to most changes in public services Read this and other original posts by Chris Bolton at www.whatsthepont.com

Antibiotic use and the rules Rule 1: by default antibiotics cause harm Rule 2: positive action: prescribe when the benefits outweigh the harms Use the wrong antibiotic: harm Positive action: check Welsh Clinical Portal

Medical device use and the rules Rule 1: by default medical devices cause harm Rule 2: positive actions: life saving in acute event Review the need on a regular basis: change/remove when negative outweigh positive

Complexity: What can I do?

Complexity: What can I do?

Complexity: What can I do?

Complexity: What can I do?

?UTI 24/04/2016 Dr M D Simmons: Clinical information asks, "?UTI." Microbiology cannot answer that question because that requires clinical insight and none provided. In older adults in particular but in younger people depending on underlying pathology, asymptomatic bacteruria can occur and antibiotics should be reserved for clinical signs of infection. Sensitivities therefore suppressed pending clinical engagement with the on-call microbiologist if indicated.

Non-UTI clinical details 24/04/2016 Dr M D Simmons: The clinical details do not describe any clinical signs of urinary infection. Asymptomatic bacteruria is not an uncommon finding as people get older and inappropriate antibiotics can lead to further selection of antibiotic resistance. Sensitivities therefore suppressed but available from the on-call microbiologist if clinically indicated.

Dipstick results only 24/04/2016 Dr M D Simmons: Dipstick results only given on the request form; no clinical information regarding signs or symptoms, which should always be the precursor to using a dipstick. Asymptomatic bacteruria is commonplace in older patients but also in younger people if there are underlying anomalies and antibiotics should be reserved for clinical signs of infection. Sensitivities therefore suppressed. Please call the on-call microbiologist if antibiotics are clinically indicated.

No clinical details 24/04/2016 Dr M D Simmons: No clinical details provided, therefore no sensitivities reported. Please call the on-call consultant if antibiotics are indicated for clinical evidence of infection. Asymptomatic bacteruria in commonplace in older patients and antibiotics are not indicated and may select for increasingly resistant organisms.

Other early interventions Simple interventions to reduce risks around IV cannulation and line associated infection Simple interventions to reduce risk of pseudobacteraemia with Staph aureus

Cannulation Pack Cannulation Pack RML506-040 4 x Swab Non Woven 7.5 x 7.5cm 4ply 1 x Cannula Insertion Label 1 x Orange Bag, Folded 1 x Dressing Tegaderm IV 7x 8.5cm Ported 1 x Paper: Tissue/PE Folded 1 x Paper: Tissue/PE 1 x Chloraprep SEPP 0.67ml Applicator 1 x Pre-Filled Saline Syringe 10ml 1 x Tourniquet

Blood culture pack Blood Culture Pack RML506-039 3 x Swab Non Woven 7.5 x 7.5cm 4ply 1 x Orange Bag Folded 2 x Cotton Wool Balls Small 1 x Paper: Blue Tissue/PE Fldd & Fen 1 x Paper: Tissue/PE 1 x Chloraprep FREPP 1.5ml 1 x Blood Collection Adaptor (Blue) 1 x Tourniquet 1 x Blood Culture Patient Label 1 x Blood Collection Set - Push Button 21g 1 x Sani Cloth port & hub prep

Outputs

Blood culture contamination   HHDB 2014 HDHB 2015 HDHB 2016 Contam 938 888 934 Total 15064 16286 17892 Rate 6.23% 5.45% 5.22%

Peripheral vascular cannulae

Central lines

HDUHB Pos/Neg Urines

HDUHB Pos/Neg by month

HDUHB Urine Samples

Top ten bacteraemia rate 2015

HDUHB Suppress/Release

Blood cultures 2013

Blood cultures 2014

Next steps? Further “Safe to fail” experiments Continue and extend engagement Empower more of our staff Swansea University Elderly Gut Health Programme Continued improvement in quality and safety

InfectionControlTeam@wales.nhs.uk www.phw.org.uk